The arrival of tirzepatide has generated considerable optimism within the medical community . This novel medication, a twin -action receptor activator , works by targeting both the GLP-1 and GIP receptors. https://miriameewo377906.pointblog.net/tirzepatide-a-emerging-hope-for-type-2-glucose-intolerance-92510401